We are live on ! Find out more
AEPBI

AH Equity Partners Bio II Portfolio holdings

AUM $144M
1-Year Est. Return 54.61%
This Fund
S&P 500
This Quarter Est. Return
-31.09%
1 Year Est. Return
-54.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$174M
AUM Growth
-$18.5M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 94.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
$72M 41.49%
17,438,465
NAUT icon
2
Nautilus Biotechnolgy
NAUT
$215M
$70.7M 40.75%
16,298,006
ERAS icon
3
Erasca
ERAS
$6.63B
$21.5M 12.39%
2,500,000
NVTA
4
DELISTED
Invitae Corporation
NVTA
$9.33M 5.37%
1,170,127

Similar funds

AH Equity Partners Bio II's Q1 2022 Portfolio in Review

As of Q1 2022, AH Equity Partners Bio II held 4 positions worth $174M, down 9.6% from $192M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. AH Equity Partners Bio II opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 91% a quarter earlier.

  • AH Equity Partners Bio II's ten largest holdings make up 100% of its $174M portfolio in Q1 2022.
  • AH Equity Partners Bio II opened 0 new positions and closed 0 in Q1 2022.
  • AH Equity Partners Bio II's portfolio value fell 9.6% quarter-over-quarter to $174M.

Based on AH Equity Partners Bio II's 13F filing for Q1 2022, filed 16 May 2022.